Purchase Order HHSN272201800474P

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to JPT Peptide Technologies GMBH for $16,844.00 on March 6, 2019. The order is for peptides under firm fixed-price terms with an ultimate completion date of May 15, 2019. Place of performance is Germany.</p>

This firm fixed price purchase order for $17,272 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to JPT Peptide Technologies GMBH of Almanya to fulfill a requirement originally solicited under Request for Quotes RFQ-NIAID-2079401. The solicitation sought 18 each of PepMix SARS-CoV-2 (Spike Glycoprotein), consisting of a mixture of 158+157 peptides for use in assay kits. JPT will deliver the requested...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,610 firm fixed price purchase order to JPT Peptide Technologies GmbH of Germany. The contract is to provide 20 units of a 158-peptide mixture and 25 units of a 102-peptide mixture related to the SARS-CoV-2 spike glycoprotein and nucleocapsid phosphoprotein, respectively, as referenced in the original solicitation. The peptides will support ongoing NIAID...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and related research products. The $3,620 firm fixed price purchase order is for the delivery of peptide microarrays displaying peptides from a previous order, in support of NIAID's research activities. The award has no set-aside...

The National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,222.30 firm fixed price purchase order contract to JPT Peptide Technologies GmbH, a foreign-owned for-profit manufacturer of custom peptides and peptide-based products. The contract supports research related to cancer, COVID-19, allergies, and infectious diseases through the provision of peptide mixtures, reagents, assay kits, laboratory testing services, drugs and biologicals....

This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to JPT Peptide Technologies GmbH, a foreign-owned for-profit manufacturer of custom peptides and related products. The contract is valued at $7,975.75 and requires the delivery of custom peptides of the Zaire Ebola virus glycoprotein, as individual and pooled aliquots, with quality control via liquid chromatography-mass...

The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,326.00 firm fixed price purchase order to JPT Peptide Technologies GMBH, a foreign-owned, for-profit manufacturer of goods, for custom peptide synthesis. The award, which did not have any set-aside designation, supports research related to cancer, COVID-19, allergies, and infectious diseases. JPT Peptide Technologies has received...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., a minority-owned for-profit organization, to provide HIV-1 peptides. The potential value of this contract is $12,801.20 and the period of performance ends on June 11, 2018. This award was not set aside for small businesses. Peptide 2.0 Inc. specializes in custom...

This is a $12,621.25 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Pepperprint GmbH, a biotech company in Heidelberg, Germany. The contract is for the custom generation of peptides to support NIAID's research efforts. Pepperprint has previously received federal contracts from the U.S. Department of Agriculture and HHS/FDA for similar peptide microarray...

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, awarded a firm fixed-price purchase order contract to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for the provision of custom HIV peptides. The contract has a ceiling value of $12,801.20 and an ultimate completion date of September 1, 2017. Peptide 2.0 Inc. is a minority-owned, for-profit business that specializes in custom peptide synthesis and...